Winston Pharmaceuticals, Inc.
OTC: WPHM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Joel E. Bernstein
- Employees
- 9
- Headquarters
- Vernon Hills, United States
- IPO year
- 2023
- Market cap
- $7.7K
- Website
- https://www.winstonlabs.com
Loading WPHM…
Loading profile data…Frequently asked questions about WPHM
What does Winston Pharmaceuticals, Inc. (WPHM) do?
Winston Pharmaceuticals, Inc. (WPHM) is a biopharmaceutical firm dedicated to the discovery, development, and market introduction of innovative treatments for pain. The company's pipeline and offerings address a broad spectrum of painful conditions, encompassing episodic cluster headaches, chronic migraines, various neuropathic pain syndromes, a...
Where does WPHM trade?
Winston Pharmaceuticals, Inc. (WPHM) trades on the Other OTC.
What sector is WPHM in?
Winston Pharmaceuticals, Inc. (WPHM) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Winston Pharmaceuticals, Inc.?
Joel E. Bernstein is the chief executive officer of Winston Pharmaceuticals, Inc. (WPHM).
Where is Winston Pharmaceuticals, Inc. headquartered?
Winston Pharmaceuticals, Inc. is headquartered in United States.
Does WPHM pay a dividend?
Winston Pharmaceuticals, Inc. (WPHM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did WPHM go public?
Winston Pharmaceuticals, Inc. (WPHM) completed its initial public offering in 2023.